Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives

El-Sayed, Nahed Nasser Eid and Almaneai, Norah M. and Ben Bacha, Abir G. and Al-Obeed, Omar A. and Ahmad, Rehan and Abdulla, Maha Hamadien and Alafeefy, Ahmed Mahmoud (2019) Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 34 (1). pp. 672-683. ISSN 1475-6366 E-ISSN 1475-6374

	PDF - Published Version Restricted to Repository staff only Download (1MB) | Request a copy
Preview	PDF (Scopus) - Supplemental Material Download (301kB) | Preview
Preview	PDF (wos) - Supplemental Material Download (355kB) | Preview

Abstract

Some new 3H-quinazolin-4-one derivatives were synthesised and screened for anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities. Compound 15d was more potent in reducing the cell viabilities of HT-29 and SW620 cells lines to 38%, 36.7%, compared to 5-FU which demonstrated cell viabilities of 65.9 and 42.7% respectively. The IC50 values of 15d were ∼20 µg/ml. Assessment of apoptotic activity revealed that 15d decreased the cell viability by down regulating Bcl2 and BclxL. Moreover, compounds, 8j, 8d/15a/15e, 5b, and 8f displayed lowered IC50 values than oleanolic acid against proinflammatory isoforms of hGV, hG-X, NmPLA2, and AmPLA2. In addition, 8d, 8h, 8j, 15a, 15b, 15e, and 15f showed better anti-α-amylase than quercetin, whereas 8g, 8h, and 8i showed higher anti-α-glucosidase activity than allopurinol. Thus, these compounds can be considered as potential antidiabetic agents. Finally, none of the compounds showed higher antiproteases or xanthine oxidase activities than the used reference drugs.

Item Type:	Article (Journal)
Additional Information:	7668/72704
Uncontrolled Keywords:	3H-quinazolin-4-one; Colorectal cancer; Metabolic syndrome; Phospholipases; Proteases
Subjects:	Q Science > QD Chemistry R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology (including Cancer)
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Science Kulliyyah of Science > Department of Chemistry
Depositing User:	Dr Ahmed Alafeefy
Date Deposited:	15 Jul 2019 10:07
Last Modified:	18 Nov 2019 00:07
URI:	http://irep.iium.edu.my/id/eprint/72704

Actions (login required)

View Item